Schering Puts on a Marketing Clinic

As allergy drug Claritin goes over-the-counter, the drugmaker is pulling out the stops to pitch its successor, Clarinex

By Amy Tsao

To continue reading this article you must be a Bloomberg Professional Service Subscriber.